BXQ-350 for pancreatic cancer and brain cancer

This is about BXQ-350 for pancreatic cancer and brain cancer:

http://news.cincinnati.com/apps/pbcs.dll/article?AID=/201310130522/NEWS10/310130052&nclick_check=1

Quote from:

Getting this far has been an achievement of its own for Bexion’s team. Fewer than 10 percent of drugs that undergo animal testing ever make it to phase 1 human trials.

And its challenges are just beginning. About 10 percent of drugs that get this far ultimately gain U.S. Food and Drug Administration approval, a total that drops to 4.7 percent for cancer drugs, according to a 2011 study.